Where innovation meets industrial reality
BioProcess International Europe 2026 stands as one of the leading European gatherings dedicated to bioprocessing and advanced biomanufacturing. The event brings together biotechnology companies, pharmaceutical leaders, CDMOs, process engineers, and regulatory experts to address one central challenge: transforming complex biological innovation into scalable and reliable manufacturing systems.
As advanced therapies, cell-based products and 3D biological models continue to reshape healthcare, production strategies are becoming a decisive factor. Innovation is no longer defined solely by scientific discovery, but by the ability to manufacture safely, reproducibly and at scale.
BioProcess International Europe provides a platform where these industrial questions are discussed openly, from early-stage development to GMP production and global deployment.
The growing importance of scalable cell production
The evolution of regenerative medicine, immunotherapy and precision oncology is accelerating. However, scaling fragile biological systems remains a structural bottleneck across the industry.
Bioprocessing today must reconcile several constraints:
-
Maintaining biological integrity
-
Ensuring process reproducibility
-
Achieving consistent scale-up
-
Aligning with regulatory and GMP frameworks
-
Reducing operational risk during industrial transition
The industry is moving beyond proof-of-concept. The focus has shifted toward robust production architectures capable of supporting clinical and commercial deployment.
This is precisely why BioProcess International Europe has become a strategic event within the European biomanufacturing ecosystem.
Why Cellura will be present
Cellura’s participation reflects a deliberate commitment to engage with the bioprocessing community at a time of structural transformation.
Our approach to 3D cell culture and gentle biomanufacturing is designed around a simple principle: scalability should never compromise biological integrity.
At BioProcess International Europe 2026, Cellura aims to:
-
Exchange with process development teams navigating scale-up challenges
-
Engage with CDMOs and biotech companies transitioning toward GMP production
-
Discuss how controlled 3D environments can support fragile cell systems
-
Contribute to conversations around reproducibility and industrial reliability
The event provides a unique opportunity to connect technological innovation with operational expertise.
A shared ambition: from lab breakthrough to industrial deployment
BioProcess International Europe emphasizes the entire manufacturing lifecycle, from early R&D to large-scale production. It highlights the need for platforms that are adaptable, controllable and aligned with evolving regulatory expectations.
For Cellura, being present at this event means participating in a broader dialogue about the future of advanced therapies and scalable cell production.
Biomanufacturing is entering a new phase. As therapies become more personalized and biologically complex, the underlying production technologies must evolve accordingly. Mechanical environments, process standardization and scalability are no longer secondary considerations. They define feasibility.
Building connections across the European bioprocessing ecosystem
One of the strengths of BioProcess International Europe lies in its capacity to create convergence. Engineers, scientists, regulatory experts and industrial leaders engage in discussions that move beyond theory.
For Cellura, this environment is essential. Direct interaction with manufacturing stakeholders ensures that technological development remains aligned with real-world constraints.
Our objective at the event is clear: To contribute to a more resilient and scalable biomanufacturing ecosystem capable of supporting the next generation of advanced healthcare solutions.
About the event
More information about BioProcess International Europe 2026 is available on the official website: https://www.bioprocessingeurope.com/
For further information or to arrange a meeting:
Email: contact@cellura.io
